Each half-dropper serving contains 40 mg CBD, 10 mg CBG, and 2.5 mg THC for balanced yet robust effects ... symptoms for those battling multiple sclerosis, chronic pain, and IBS, but outcomes can ...

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Irritable bowel syndrome, or IBS, is among the most common gastrointestinal conditions today. It affects some 10% to 15% of people in the U.S., per the American College of Gastroenterology.

(Nature Reviews Gastroenterology & Hepatology) Subgroup analysis of the ATLANTIS trial of the antidepressant amitriptyline for irritable bowel syndrome (IBS) showed a greater degree of benefit in ...

My belly would sometimes bloat so much that I looked like I was six months pregnant. And the pain? As the gas expanded, it ...

Kochi: In a major achievement in the solid waste treatment sector, compressed biogas (CBG) plant at Brahmapuram is set to start its operations. Construction of the plant will be completed by the ...

New research suggests that δ-receptor agonists regulate intestinal motility and relieve abdominal pain in a mouse model of irritable bowel syndrome, potentially offering a novel CNS-targeted ...

Treatment for irritable bowel syndrome (IBS) may start with lifestyle changes like avoiding certain foods and relieving stress. If these don’t work, some medications may help relieve symptoms.

Background: The aim of this study was to develop and psychometrically test a short, patient-reported questionnaire to be used in clinical practice for patients with Irritable Bowel Syndrome (IBS).